Results

Total Results: 7,637 records

Showing results for "therapy".

  1. www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - which was unconfirmed) of fatal gastrointestinal hemorrhage was reported in this group in 5 years of treatment … It is possible that high-dose therapy may even have less platelet-inhibitory effect than low-dose therapy … risks of aspirin therapy before beginning treatment. … Foster JW, Hart RG Antithrombotic therapy for cerebrovascular disease: prevention and treatment of stroke … Fuster V, Dyken ML, Vokonas PS, et al Aspirin as a therapeutic agent in cardiovascular disease.
  2. psnet.ahrq.gov/web-mm/anticoagulation-held-too-long
    April 01, 2008 - heart valves (as in this case), prevention of stroke in atrial fibrillation (a heart arrhythmia), and treatment … al; Italian Federation of Centers for the Diagnosis of Thrombosis and Management of Antithrombotic Therapies … Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term … • Consider the efficacy of therapeutic anticoagulation in preventing thromboembolism. … June 16, 2019 Heparin: improving treatment and reducing risk of harm.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0404_01-14-2011.pdf
    January 01, 2011 - Summary: The nominator is interested in the effectiveness and comparative effectiveness of medical treatments … Compare two newer drug therapies, both FDA approved, for the treatment of PAH (inhaled treprostinil … and ambrisentan) to older treatments b. … Compare combination drug therapies to monotherapy drug treatment Pulmonary Arterial Hypertension … Based on disease etiology and severity of the disease, the timing and optimal combinations of drug therapy
  4. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/74271/psn-pdf
    January 19, 2022 - Improving shared situation awareness for high-risk therapies in hospitalized children. … Improving shared situation awareness for high-risk therapies in hospitalized children. … https://psnet.ahrq.gov/issue/improving-shared-situation-awareness-high-risk-therapies-hospitalized-children … implementation, the percentage of electronic health record (EHR) alerts correctly describing high-risk therapies … https://psnet.ahrq.gov/issue/improving-shared-situation-awareness-high-risk-therapies-hospitalized-children
  5. digital.ahrq.gov/sites/default/files/docs/citation/r21hs022938-mitchell-final-report-2017.pdf
    January 01, 2017 - While depression is a treatable condition, less than 36% of people with depression receive effective treatment … .3 Cognitive behavioral Therapy (CBT) is an effective approach to depression treatment for people with … chronic disease but attending treatment sessions can be challenging.4,5 An alternative to computerized … scores range from lowest score of 44 to highest score of 201, with higher scores correlated with higher therapeutic … COPD education and cognitive behavioral therapy group treatment for clinically significant symptoms of
  6. digital.ahrq.gov/sites/default/files/docs/publication/eaap_trainpresentfinalimplementation_080211comp.pdf
    January 01, 2007 - and improve outcomes” (p93)  “Provide all patients with a written asthma action plan for daily treatment … frequency of symptoms  Asthma Severity or Control determined by the application  Recommendation for treatment … and improve outcomes” (p93)  “Provide all patients with a written asthma action plan for daily treatment … Antibiotic use  Written Asthma Action Plans (WAAP) and Peak Flow meters (PFM)  Effects of early treatment … to evaluate how/if the treatments are working  What are we looking for at this follow- up visit?
  7. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018665-storch-final-report-2015.pdf
    January 01, 2015 - the needs of each client and, depending on the design, could lack important therapeutic components. … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … A randomized controlled trial of computer-assisted cognitive-behavioral therapy versus treatment as … CCBT=Computer-assisted cognitive-behavioral therapy; TAU=treatment as usual; PARS=Pediatric Anxiety
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
    June 20, 2013 - Topic 0552 Low Back Pain NSD FINAL SJ Diagnosis and Treatment of Low … The nominator is also interested in the harms and benefits of the treatment options. … interventions for secondary prevention or prevention of flares of low back pain, and combination therapy … and related therapies, massage, and various psychological therapies) 6. … What are the comparative benefits and harms of combinations of therapies (versus single therapies or
  9. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27811/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  10. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27801/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  11. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27796/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  12. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27781/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  13. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27806/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  14. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27816/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  15. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27771/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  16. Rule 1 Test Cases (xls file)

    cds.ahrq.gov/sites/default/files/cds/artifact/27776/Test-Cases.xlsx
    October 28, 2021 - Assume one alt-Step 2 therapy to another and give Rec 2: Step 2 before advancing adult-step2bB-asthma … Assume one alt-Step 3 therapy to another and give Rec 4: Step 3 before advancing adult-step3b-asthma … diagnosis 1 LTRA (montelukast) Rule 4 recommendation given no no med-dose ICS + LTRA is alt Step 4 therapy … ) Rule 5 recommendation given no no none 5: Step 3-to-4 transition adult-step3-asthma on low SMART therapy … item 1 LAMA (tiotropium) Rule 5 recommendation given no no give recommendation for preferred Step 4 therapy
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
    December 09, 2009 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional therapies intended to modify the core symptoms of ASD Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate specific medical therapies from the review as treatments are typically
  18. effectivehealthcare.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
    January 01, 2010 - gains once active therapy ends. … treatment or across treatments? … including music therapy and nutritional therapies intended to modify the core symptoms of ASD Comparators … interventions (e.g., autism, asperger, pervasive development, therapeutics, etc.). … This revision does not eliminate specific medical therapies from the review as treatments are typically
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0264_01-14-2008.pdf
    January 01, 2008 - the comparative effectiveness of disease-modifying antirheumatic drugs (DMARDs) and other medical treatments … for the treatment of juvenile idiopathic arthritis. … and have no disease-modifying properties)) Outcome(s): Potential harms and benefits of various treatments … subgroups of patients based on stage of disease, history of prior therapy, demographics, concomitant … therapies, or comorbidities?
  20. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/44231/psn-pdf
    January 22, 2016 - Just-in-time training for high-risk low-volume therapies: an approach to ensure patient safety. … Just-in-Time Training for High-Risk Low-Volume Therapies: An Approach to Ensure Patient Safety. … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient … and competency shortcomings for bedside nurses on an as-needed basis, given the demands of complex treatments … https://psnet.ahrq.gov/issue/just-time-training-high-risk-low-volume-therapies-approach-ensure-patient-safety